Supra-arch branch vessel bypass and thoracic endovascular aortic repair for treating type B1C aortic dissection
- VernacularTitle:头臂血管转流并主动脉覆膜支架植入术在 Stanford B1C 型主动脉夹层中的应用
- Author:
CUI Cong
1
;
ZHANG Li
1
;
GAO Xia
1
;
ZHANG Xianghui
1
;
SUN Kexiong
1
;
XIAO Changbo
1
;
WU Gang
1
;
MA Shen
1
;
CHEN Yuxin
1
;
WANG Pingfan
1
Author Information
- Publication Type:Journal Article
- Keywords: Type B1C aortic dissection; supra-arch branch vessel bypass; hybrid procedure; stent graft
- From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2019;26(2):121-124
- CountryChina
- Language:Chinese
- Abstract: Objective To evaluate the results of a hybrid procedure for treating Stanford type B1C aortic dissection. Methods In our center, 49 patients with Stanford type B1C aortic dissection underwent supra-arch branch vessel bypass and thoracic endovascular aortic repair (TEVAR) from December 2013 to December 2017. There were 33 males and 16 females with an average age of 60.4±5.5 years. Left common carotid artery to left subclavian artery bypass (n=29), right common carotid artery to left common carotid artery and left subclavian artery bypass (n=18), left common carotid artery to left subclavian artery and right common carotid artery to right subclavian artery bypass (n=2) were performed. Results Early mortality rate was 2.0% (1/49). Forty-eight patients survived postoperatively. The follow-up rate was 100.0% (48/48). The patients were followed up for 6 to 47 (26.8±11.9) months postoperatively. Chest pain relapsed in one patient 8 months after the operation. The whole aorta CTA showed type A1S aortic dissection in one patient 6 months after the operation, and the re-operation was satisfactory. There was no endoleak or paraplegia. Conclusion Initial results suggest that the one-stage hybrid procedure is a suitable therapeutic option for type B1C aortic dissection.
